Surgical management of medically-refractory hyperinsulinism
bit.ly shows its articles on its own site.
Read the article on bit.ly ↗Article · Aug 2020 · 1 min read
In brief
In brief
Retrospective study of 11 pediatric patients with medically-refractory hyperinsulinism shows focal lesions (CHI and insulinoma) are cured by localized resection, while diffuse CHI requires near-total pancreatectomy with variable outcomes. PET-CT imaging localized 66% of focal lesions; diffuse disease carries risks of diabetes and persistent hypoglycemia despite aggressive resection.
Written by the GCMD Library team from the article.
Background: Congenital hyperinsulinism (CHI) and insulinomas are the most common causes of medically-refractory pediatric hyperinsulinism.
Methods: Children with CHI or insulinoma treated from 1/1/2014-1/1/2019 at an academic center were retrospectively analyzed. Primary outcome was persistent intravenous dextrose requirement at discharge.
Results: Eleven patients were identified: six with diffuse-type CHI, three with focal-type CHI, two with insulinoma. Median age at diagnosis was 20 days (1 day-16 years). Preoperative functional imaging (18F-Fluoro-l-DOPA PET-CT scan) accurately localized 66% of focal-type CHI lesions. All patients with focal-type CHI and insulinoma were cured by local resection. All patients with diffuse-type CHI underwent near-total pancreatectomy (NTP): four patients were cured of hyperinsulinism, of which 2 developed insulin-dependent diabetes, while two patients were palliated to home enteral glucose infusion.
Conclusions: Localized resection cures children with focal, insulin-secreting lesions. NTP may cure diffuse-type CHI; potential complications include diabetes, exocrine insufficiency, and persistent hypoglycemia from residual hypersecreting pancreatic tissue.
Summary: Congenital hyperinsulinism (CHI) and insulinomas are the most common causes of medically-refractory pediatric hyperinsulinism, causing potential complications including permanent brain injury. 18F-Fluoro-l-DOPA PET-CT scan can be used to localize focal insulin-secretion lesions preoperatively. Focal-type CHI and insulinoma are cured by localized resection. Diffuse-type CHI requires near-total pancreatectomy for cure, but complications include diabetes, exocrine insufficiency, or persistent hypoglycemia from residual foci of hypersecreting pancreatic tissue.
DOI: 10.1016/j.amjsurg.2019.09.003